Share This Page
Drug Price Trends for AMLODIPINE-VALSARTAN
✉ Email this page to a colleague
Average Pharmacy Cost for AMLODIPINE-VALSARTAN
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
AMLODIPINE-VALSARTAN 10-160 MG | 23155-0845-03 | 0.47623 | EACH | 2024-12-18 |
AMLODIPINE-VALSARTAN 10-160 MG | 62332-0206-30 | 0.47623 | EACH | 2024-12-18 |
AMLODIPINE-VALSARTAN 10-160 MG | 62332-0206-90 | 0.47623 | EACH | 2024-12-18 |
AMLODIPINE-VALSARTAN 10-160 MG | 23155-0845-09 | 0.47623 | EACH | 2024-12-18 |
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB | 65862-0835-30 | 6.78193 | EACH | 2024-12-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Amlodipine-Valsartan
Introduction
Amlodipine-valsartan, a combination drug used to treat high blood pressure, is a significant player in the antihypertensive market. This analysis will delve into the current market trends, sales data, price projections, and forecasted growth for this medication.
Market Size and Growth
The global market for amlodipine-valsartan tablets has been growing steadily. As of 2023, the market was valued at US$ 420 million and is anticipated to reach US$ 696.8 million by 2030, with a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period of 2024-2030[4].
Sales Trends and Forecast
Historical sales data indicate that amlodipine-valsartan has seen consistent growth. The sales forecast suggests continued expansion, driven by increasing demand for effective antihypertensive treatments. The report from ResearchAndMarkets.com provides detailed sales forecasts by country, which is crucial for market planning, market sizing, and competitive intelligence[1].
Pricing Analysis
The pricing of amlodipine-valsartan varies based on the dosage and the pharmacy. For example, a 30-tablet supply of amlodipine-valsartan (10 mg-160 mg) can cost around $38.35, while a 30-tablet supply of amlodipine-valsartan (10 mg-320 mg) can cost approximately $45.45 for cash-paying customers[2].
Price Breakdown
- 10 mg-160 mg: $38.35 for 30 tablets, with a per-unit price of $1.28[2].
- 10 mg-320 mg: $45.45 for 30 tablets, with a per-unit price of $1.52[2].
- 5 mg-160 mg: $34.23 for 30 tablets, with a per-unit price of $1.14[2].
Regional Market Analysis
The market for amlodipine-valsartan is segmented across various regions, including North America, Europe, Asia Pacific, South America, and the Middle East and Africa. Each region has its own market size, growth trends, and competitive landscape.
- North America: This region is one of the largest markets for amlodipine-valsartan, driven by high healthcare spending and a large patient population.
- Europe: Countries like Germany, France, and the UK contribute significantly to the European market.
- Asia Pacific: This region is expected to see rapid growth due to increasing healthcare infrastructure and a growing patient base in countries like China and India[4].
Competitive Landscape
The market for amlodipine-valsartan is competitive, with several key players involved. These include:
- Novartis Pharma: Known for its brand name Exforge.
- Baiao Pharma
- Brilliant Pharma
- Hengrui Pharma
- Huahai Pharma
- Lepu Pharma
- Wangao Pharma[4].
These companies compete on the basis of pricing, product quality, and market reach.
Technological Trends and New Product Developments
The antihypertensive market is continuously evolving with new product developments and technological advancements. For instance, the combination of amlodipine with other antihypertensive agents like hydrochlorothiazide (Exforge HCT) is gaining traction, offering more comprehensive treatment options for patients[5].
Market Segmentation
The global amlodipine-valsartan market is segmented by type and application:
- By Type: Different dosages and combinations (e.g., Valsartan and Amlodipine Tablets I and II).
- By Application: Hospital, clinic, and other healthcare settings[4].
Impact of COVID-19
The COVID-19 pandemic has highlighted the importance of robust healthcare systems and the need for effective treatments for chronic conditions like hypertension. This has led to increased demand for antihypertensive medications, including amlodipine-valsartan[4].
Price Projections
Given the forecasted growth rate of 7.5% from 2024 to 2030, the prices of amlodipine-valsartan are expected to remain competitive. However, prices may fluctuate based on factors such as production costs, regulatory changes, and market competition.
Future Pricing Scenarios
- Short-term: Prices are likely to remain stable, with minor adjustments based on market dynamics.
- Long-term: As the market grows, there could be slight increases in prices due to increased demand and potential supply chain costs[4].
Key Takeaways
- The global amlodipine-valsartan market is projected to grow significantly, reaching US$ 696.8 million by 2030.
- Pricing varies by dosage and region, with competitive pricing strategies in place.
- The market is segmented by region, type, and application, with key players competing for market share.
- Technological trends and new product developments are driving market growth.
- The COVID-19 pandemic has emphasized the need for effective antihypertensive treatments.
FAQs
What is the current market size of amlodipine-valsartan tablets?
The global market for amlodipine-valsartan tablets was valued at US$ 420 million in 2023[4].
What is the forecasted growth rate for the amlodipine-valsartan market?
The market is expected to grow at a CAGR of 7.5% from 2024 to 2030[4].
Which regions are the largest markets for amlodipine-valsartan?
North America, Europe, and the Asia Pacific are among the largest markets for amlodipine-valsartan[4].
What are the brand names for amlodipine-valsartan?
The brand name for amlodipine-valsartan is Exforge[2].
How does the COVID-19 pandemic impact the amlodipine-valsartan market?
The pandemic has increased the demand for antihypertensive medications, including amlodipine-valsartan, due to the emphasis on managing chronic conditions during the health crisis[4].
Sources
- Business Wire: "2017 Amlodipine / Valsartan Sales, Price Analysis, & Sales Forecast - 2017"[1].
- Drugs.com: "Amlodipine/valsartan Prices, Coupons, Copay Cards & Patient Assistance"[2].
- iHealthcareAnalyst: "Antihypertensive Drugs Market and Forecast 2024-2031"[3].
- QYResearch: "Global Valsartan and Amlodipine Tablets Market Research Report 2024"[4].
- Drugs.com: "Amlodipine/hydrochlorothiazide/valsartan Prices, Coupons, Copay Cards & Patient Assistance"[5].
More… ↓